Biomarkers
Biomarkers play a critical role in improving the diagnosis and monitoring of Alzheimer’s disease. These resources offer expert recommendations to help clinicians understand when and how to use biomarker testing in practice.
Explore Current Recommendations for Using Alzheimer's Biomarkers in Clinical Settings.
Guidance on the appropriate use of CSF and blood-based biomarkers to support diagnosis and care planning.
Detection and Diagnosis
Clinical Practice Guideline: Blood-Based Biomarkers in Specialty Care
The blood-based biomarker guideline helps clinicians incorporate these emerging tools into the diagnostic process. It reflects the growing evidence that blood tests can support earlier, more accurate diagnosis of Alzheimer’s disease.
Detection and Diagnosis
Appropriate Use Criteria: Lumbar Puncture and Cerebrospinal Fluid Testing
These expert consensus recommendations guide the safe and effective use of cerebrospinal fluid testing to detect Alzheimer’s pathology. Includes criteria for patient selection and clinical application.
Detection and Diagnosis
Standardized Blood-Based Biomarkers Sample Handling Workflow
A stepwise evidence-based workflow for optimized blood sample collection and processing to ensure reliable Alzheimer’s biomarker measurement.
Detection and Diagnosis
Evidence-Based Standardized Sample Handling Protocol for Blood-Based AD Biomarker Measurement
Multi-center consensus research article on the development of an evidence-based, standardized pre-analytical sample handling protocol.
Detection and Diagnosis
Preferred Methodological Reporting for Blood-Based Biomarker Research
Preferred reporting practices for blood-based biomarker research to strengthen evidence synthesis and guideline development.
See Related Content
You may also like these related items.
